$SUPN

$40.96 +$0.19 (0.47%) Close

$SUPN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$SUPN Management Team

Mr. Peter Vozzo

Investor Relations

Age -

Compensation -

Sex Male

Mr. Charles Newhall

Independent Chairman of the Board

Age 80

Compensation $399.7K USD

Sex Male

Mr. Jack Khattar

President

Chief Executive Officer

Secretary

Director

Age 63

Compensation $12.65M USD

Sex Male

Mr. Timothy Dec

Chief Financial Officer

Senior Vice President

Age 66

Compensation $2.295M USD

Sex Male

Mr. Frank Mottola

Chief Operating Officer

Chief Technology Officer

Age 53

Compensation $1.345M USD

Sex Male

Dr. Padmanabh Bhatt

Senior Vice President - Intellectual Property

Chief Scientific Officer

Age 67

Compensation $1.278M USD

Sex Male

Dr. Jonathan Rubin

Senior Vice President

Chief Medical Officer - Research and Development

Age 63

Compensation $1.484M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Peter Vozzo Investor Relations	-	-	Male
Mr. Charles Newhall Independent Chairman of the Board	80	$399.7K USD	Male
Mr. Jack Khattar President Chief Executive Officer Secretary Director	63	$12.65M USD	Male
Mr. Timothy Dec Chief Financial Officer Senior Vice President	66	$2.295M USD	Male
Mr. Frank Mottola Chief Operating Officer Chief Technology Officer	53	$1.345M USD	Male
Dr. Padmanabh Bhatt Senior Vice President - Intellectual Property Chief Scientific Officer	67	$1.278M USD	Male
Dr. Jonathan Rubin Senior Vice President Chief Medical Officer - Research and Development	63	$1.484M USD	Male

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

3 of 4

stated in the proxy; 2 not stated

Average tenure

13.3 years

from year joined

CEO also chairs the board

Charles W. Newhall, III

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Carrolee Barlow	62	2018 8 years	Not stated	None stated	None stated	Not stated
Jack A. Khattar CEO	64	2005 21 years	Not independent	None stated	Cognition Therapeutics Inc.	Paid as CEO
Frederick M. Hudson	80	2010 16 years	Independent	None stated	None stated	$385,013
Charles W. Newhall, III Board chair	81	2005 21 years	Not stated	None stated	None stated	$417,013
Georges Gemayel	65	2015 11 years	Independent	Audit Committee	Disc Medicine Inc.	$398,513
Bethany L. Sensenig	50	2023 3 years	Independent	Audit Committee	Alpha Cognition, Kalvista Pharmaceuticals, Inc.	$362,513

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 30, 2026

adult daughter of Mr. Khattar

$177,192

2025

Employment of Mr. Khattar's adult daughter as an Associate Director, Digital Marketing in a non-executive, managerial capacity; employment ended in December 2025.

Open in proxy

Comments

Company Executives

$SUPN Management Team

Mr. Peter Vozzo

Mr. Charles Newhall

Mr. Jack Khattar

Mr. Timothy Dec

Mr. Frank Mottola

Dr. Padmanabh Bhatt

Dr. Jonathan Rubin

Board of Directors

Related-party transactions